Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Cash Flow Quality Index
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Cash Flow Quality Index of 0.90x as of December 2024. Operating cash flow of CN¥24.04 Million is below net income of CN¥26.57 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Hunan Dajiaweikang Pharmaceutical Indust to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Hunan Dajiaweikang Pharmaceutical Indust to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2024)
Year-by-year earnings quality comparison for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. For live market cap and the full company financial profile, see 301126 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.90x | CN¥24.04 Million | CN¥26.57 Million | ▲ +14.4% |
| 2023 | 0.79x | CN¥27.13 Million | CN¥34.30 Million | ▲ +108.2% |
| 2022 | -9.66x | CN¥-493.96 Million | CN¥51.12 Million | ▼ -307.6% |
| 2021 | -2.37x | CN¥-161.81 Million | CN¥68.26 Million | ▼ -1.5% |
| 2020 | -2.34x | CN¥-151.46 Million | CN¥64.85 Million | ▼ -250.6% |
| 2019 | 1.55x | CN¥135.91 Million | CN¥87.65 Million | — |